Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2004
11/17/2004EP1105503B1 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1)
11/17/2004EP1078266B1 HUMAN CHROMOGRANIN A (GgA) IMMUNOLOGIC ASSAY, ANTIBODIES, REAGENTS AND KITS FOR SAID ASSAY
11/17/2004EP1073733B1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
11/17/2004EP1055125B1 Interaction between cyclin d1 and steroid receptor co-activators
11/17/2004EP1040193B1 Promoter from ashbya gossypii
11/17/2004EP0990029A4 Phytochrome regulated transcription factor for control of higher plant development
11/17/2004EP0981369B1 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
11/17/2004EP0979245B1 Oligopeptidic inhibitors of elastases and methods of preparation thereof
11/17/2004EP0943003B1 Insulin-like growth factor i (igf-i) expression system and methods of use
11/17/2004EP0942928B1 Subunit respiratory syncytial virus vaccine preparation
11/17/2004EP0920501B8 Neuritin, a neurogene
11/17/2004EP0907658B1 Neuropeptide y agonists
11/17/2004EP0904093A4 Administration of polypeptide growth factors following central nervous system ischemia or trauma
11/17/2004EP0897392B1 Peptides binding sh3 domain of cortactin and their use
11/17/2004EP0868524B1 Improved barstar gene
11/17/2004EP0860446B1 Type cc chemokine-like protein
11/17/2004EP0852502B1 Lantibiotic mutants and chimeras of enhanced stability and activity
11/17/2004EP0832185B1 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
11/17/2004EP0819763B1 Engineered acarid allergen and process for producing the same
11/17/2004EP0801657B1 Retinoid x receptor-interacting polypeptides and related molecules and methods
11/17/2004EP0731811B1 Chaperonin 10
11/17/2004EP0726957B1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES
11/17/2004CN1547617A Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof
11/17/2004CN1547610A DNA for achieving high expression of growth hormone and use thereof
11/17/2004CN1547608A Modified factor IX
11/17/2004CN1547589A Gene controlling life span of leaves in plants and method for controlling life span of plants using the gene
11/17/2004CN1547588A Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
11/17/2004CN1547587A Process for the selection of HIV-1 subtype C isolates, selected HIV-1 subtype isolates, their genes and modifications and derivatives thereof
11/17/2004CN1547586A Increased recovery of active proteins
11/17/2004CN1547483A New use of ARTEMIN, a member of the GDNF ligand family
11/17/2004CN1546666A Bacterial leaf spot resistance related gene of rice, protein and its uses
11/17/2004CN1546665A Rice blast resistance related gene of wild rice, protein and uses
11/17/2004CN1546663A Secretion and expression of high sweetness monellin by Pichia pastoris
11/17/2004CN1546525A Method for extracting protease A inhibitor and its application
11/17/2004CN1546524A Method for extracting albumin transferrin with iron supplemented and antibacterial function
11/17/2004CN1546523A PEG poly-beta peptide and its preparation method
11/17/2004CN1546520A Method for separation and purification of streptavidin by means of nano magnetic particles
11/17/2004CN1176099C Natural dissociation essence Gamma gene and antineoplastic active polypeptide dissociation essence Gamma
11/17/2004CA2470177A1 System and method for controlling user interface properties with data
11/16/2004US6820011 Three-dimensional structure of complement receptor type 2 and uses thereof
11/16/2004US6818807 Herbicide tolerant cotton plants having event EE-GH1
11/16/2004US6818805 Phosphatase stress-related proteins and methods of use in plants
11/16/2004US6818758 Estrogen receptor beta variants and methods of detection thereof
11/16/2004US6818757 Nucleotide sequences coding preferential regulatory elements; for use in controlling heart gene expression; for use in induction of embryonic and bone marrow cells; for detection of heart associated differentiation
11/16/2004US6818756 Polypeptide for use in the generation of disease and stress resistant plants
11/16/2004US6818754 For therapy/diagnosis/research; forensics/genetic mapping/mutation detection
11/16/2004US6818752 Synthetic genes for enhanced expression
11/16/2004US6818751 Antigen presenting cell expressing prostate-specific protein; for prevention/monitoring
11/16/2004US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
11/16/2004US6818747 Gαq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors
11/16/2004US6818745 For diagnosis/treatment of tumors; drug screening of antitumor agents; metastatic-tumor excreted phosphaturic-element (mepe/phosphatonin)
11/16/2004US6818744 For diagnosis/prevention/treatment of neoplasia; antitumor agents
11/16/2004US6818743 Intercellular adhesion molecule (i-cam) for modulation of ligand/receptor binding/cloning reactions; drug screening of antiinflammatory/anticancer agents; genetic engineering
11/16/2004US6818741 Alpha-fetoprotein peptides and uses therof
11/16/2004US6818740 For drug screening polymerase/protease inhibitors; envelope proteins
11/16/2004US6818739 Somatostatins
11/16/2004US6818738 Pulmonary insulin crystals
11/16/2004US6818628 For inducing in a bovine host an immunological response against bovine respiratory syncytial virus or bovine viral diarrhea virus
11/16/2004US6818627 Nuclear localization sequence fragment of hiv-1 vpr protein conjugated to nucleotide; drug delivery, antiproliferative agents
11/16/2004US6818623 Active hedgehog protein conjugate
11/16/2004US6818621 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/16/2004US6818620 Polypeptides
11/16/2004US6818619 Chimeric natriuretic peptides
11/16/2004US6818618 Hyperplasia, restenosis, and atherosclerosis treatment with polypeptide
11/16/2004US6818617 EC-3, an inhibitor of α4β1 and α4β7 integrins
11/16/2004US6818616 Neutrophil inhibitory factor inhibits adhesion to vascular endothelial cells; genetically engineered polypeptides; may include nematodal glycoprotein; antiinflammatory agents
11/16/2004US6818611 Stabilized bioactive peptides and methods of identification, synthesis and use
11/16/2004US6818448 Isolated cell comprising HAPP 670/671 DNAS sequences
11/16/2004US6818446 Compositions and methods for the analysis of mucin gene expression and identification of drugs having the ability to inhibit mucin gene expression
11/16/2004US6818445 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/16/2004US6818444 Nucleotide sequences coding preferential polypeptide for use in treatment of immune defects in animals; for use in veterinary medicine
11/16/2004US6818443 Fluorescent proteins
11/16/2004US6818442 A plasmid carrying gag, protease, envelop gene and rev gene, all derived from simian immunodeficiency virus (siv) but not tat and nef gene used for aids infection and also for therapeutical agent for aids
11/16/2004US6818440 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders and alzheimer's
11/16/2004US6818439 Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders
11/16/2004US6818425 RNA ligase of bacteriophage RM 378
11/16/2004US6818418 Protein scaffolds for antibody mimics and other binding proteins
11/16/2004US6818412 For diagnosis and therapy
11/16/2004US6818409 Isolation and purification of Clostridium botulinum toxins
11/16/2004US6818407 Microbiocidal peptide for use in the treatment of respiratory system disorders
11/16/2004US6818405 Diagnosis and treatment of osteoporosis; obtain humans, administer modulator, monitor response to modulator
11/16/2004US6818393 For determining susceptibility to diseases/characteristics as a donor or acceptor of tissue/organ transplants; for prevention/therapeutics; major histocompatibility complex
11/16/2004US6818392 Monoclonal antibodies to human immunodeficiency virus and uses thereof
11/16/2004US6818391 Glutamate transporters
11/16/2004US6818223 Abundant extracellular products and methods for their production and use
11/16/2004US6818222 Particularly from pertussis, cholera and heat labile e. coli
11/16/2004US6818220 Vascular endothelial growth factor C (VEGF-C) protein and gene mutants thereof, and uses thereof
11/16/2004US6818219 Reagent for detecting and monitoring viral infections
11/16/2004US6818217 Immunoreactive peptides
11/16/2004US6818215 Antibodies to senescent cell-derived inhibiters of DNA synthesis
11/16/2004US6818214 Modulating cell proliferation or apoptosis comprising modulating psoriastatin activity
11/16/2004US6818210 Introducing non-tumorogenic skeletal myoblasts or cardiomyocytes in myocardial tissue of the animal so as to form a stable myocardial graft, can be used, to deliver recombinant proteins directly to the heart
11/16/2004CA2159109C Therapeutic uses of keratinocyte growth factor
11/16/2004CA2120342C Epstein-barr virus peptides and antibodies against these peptides
11/16/2004CA2074719C Calcium channel compositions and methods
11/16/2004CA2059692C Pneumoccoccal polysaccharide conjugate vaccine
11/11/2004WO2004097425A2 Method of selecting chemokine antagonists and agonists
11/11/2004WO2004097421A2 Diagnostics and therapeutics for diseases associated with calcitonin receptor-like receptor (calcrl)
11/11/2004WO2004097420A1 Method for the detection of a neurological dementia disease associated with a loss of short or long term memory, corresponding prosaas peptide and detection reagents
11/11/2004WO2004097406A2 Nϵ AND/OR Nα DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH [M(OH2)3(CO)3]+ BY FAC COORDINATION